Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

Go back to Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer
(AMEX: MKKGY) Delayed: 32.91 +0.68 (2.11%)
Previous Close $32.23    52 Week High $ 
Open $32.85    52 Week Low $ 
Day High $33.10    P/E N/A 
Day Low $32.82    EPS $ 
Volume 51,199       

Merck & Co. (NYSE: MRK) Delayed: 147.24 -2.64 (1.76%)
Previous Close $149.88    52 Week High $65.46 
Open $151.05    52 Week Low $47.97 
Day High $154.02    P/E 100.16 
Day Low $144.07    EPS $1.47 
Volume 19,029,194       

Merck & Co. (NYSE: MRK) Delayed: 147.24 -2.64 (1.76%)
Previous Close $149.88    52 Week High $65.46 
Open $151.05    52 Week Low $47.97 
Day High $154.02    P/E 100.16 
Day Low $144.07    EPS $1.47 
Volume 19,029,194       

BANK OF AMERICA, STARS LINKED TO THE S&P 500 DUE 4/5/2011 (NYSE: SEO) Delayed: 11.83 --0 (-0%)
Previous Close $11.83    52 Week High $29.87 
Open $1152.15    52 Week Low $9.86 
Day High $11.83    P/E N/A 
Day Low $11.83    EPS $0.00 
Volume 23,583